2011, Number 2
<< Back Next >>
Acta Med 2011; 9 (2)
Recurrence of clear cell localized renal carcinoma
Terrazas MRA, Moreno SE, Raffoul CI, Romero LP
Language: Spanish
References: 10
Page: 103-105
PDF size: 266.62 Kb.
Text Extraction
No abstract
REFERENCES
Jemal A, Siegel R, Ward E et al. Cancer statistics. CA Cancer J Clin 2009; 59: 225.
Hofmann HS, Neef H, Krohe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 2005; 48(1): 77-81.
MacMahon H, Austin JH, Gamsu G et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005; 237(2): 395-400.
Swensen SJ, Silverstein MD, Ilstrup DM et al. The probability of malignancy in solitary pulmonary nodules. Aplication to small radiologically indeterminate nodules. Arch Intern Med 1997; 157: 849-855.
Shvarts O, Lam JS, Kim HL et al. Eastern Cooperative Oncology Group performance status predicts bone metastasis in patients presenting with renal cell carcinoma: implication for preoperative bone scans. J Urol 2004; 172(3): 867-70.
Kavolius JP, Mastorakos DP, Pavlovich C et al. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998; 16(6): 2261-6.
Han KR, Pantuck AJ, Bui MH et al. Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma. Urology 2003; 61(2): 314-9.
Richie JP. Role of surgery in patients with metastatic renal cell carcinoma. UpToDate 2010; 18-2.
Escudier BJ, Bellmunt J, Negrier S et al. Final results of the phase III, randomized, double-blind AVOREN trial of first-line bevacizumab (BEV) + interferon- 945;2a in metastatic renal cell carcinoma. J Clin Oncol 2009; 27: 239.
Hudes G, Carducci M, Tomczak P et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. N Engl J Med 2007; 356(22): 2271-81.
Full text